949109-35-7 Usage
Uses
Used in Organic Synthesis:
(S)-tert-butyl 3-hydroxypropyl(2-(2-nitrophenylsulfonylamide)propyl)carbamate is used as an intermediate in organic synthesis for its unique structural features, including the tert-butyl group and the carbamate functional group. These characteristics allow it to be a versatile building block in the creation of more complex molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, (S)-tert-butyl 3-hydroxypropyl(2-(2-nitrophenylsulfonylamide)propyl)carbamate is used as a potential candidate for drug development due to its complex chemical structure and the presence of bioactive functional groups. It may be further modified or used as a starting point for the synthesis of new therapeutic agents.
Used in Materials Science:
(S)-tert-butyl 3-hydroxypropyl(2-(2-nitrophenylsulfonylamide)propyl)carbamate may also find applications in materials science, where its unique structural elements could be exploited to create novel materials with specific properties, such as improved stability or reactivity in certain conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 949109-35-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,9,1,0 and 9 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 949109-35:
(8*9)+(7*4)+(6*9)+(5*1)+(4*0)+(3*9)+(2*3)+(1*5)=197
197 % 10 = 7
So 949109-35-7 is a valid CAS Registry Number.
949109-35-7Relevant academic research and scientific papers
Synthesis of oxidative metabolites of K-115, a novel Rho-kinase inhibitor
Gomi, Noriaki,Shibuya, Kimiyuki,Kawamura, Kiyoshi,Kabeya, Mototsugu
, (2022/02/01)
In humans, oxidative metabolites 2–4 of (S)-4-fluoro-5-(2-methyl-1,4-diazepan-1-ylsulfonyl)-isoquinoline hydrochloride dihydrate (K-115, 1), a novel Rho-kinase inhibitor, are mainly formed by aldehyde oxidase and CYP3A4 / 3A5 in human liver S9 and hepatoc
NOVEL PRODUCTION METHOD FOR ISOQUINOLINE DERIVATIVES AND SALTS THEREOF
-
, (2013/06/26)
The present invention provides a method capable of industrially producing a target product, i.e., a compound represented by the aforementioned formula (I) or a salt thereof, which is useful for preventing and treating cerebrovascular disorders such as cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage, and cerebral edema, particularly for preventing and treating glaucoma, at high yield even on a large scale without imposing a negative impact on the environment. The present invention provides a method for producing a compound represented by formula (I) or a salt thereof, wherein the method comprises a step of reacting a compound represented by formula (III) or a salt thereof with a compound represented by formula (II) in the presence of at least one solvent selected from the group consisting of a nitrile solvent, an amide solvent, a sulfoxide solvent, and a urea solvent, and a base.
